Reactivity | HuSpecies Glossary |
Applications | Bioactivity |
Format | Carrier-Free |
Details of Functionality | Measured by its binding ability in a functional ELISA. When Recombinant Human (rh) USAG1 is coated at 2 μg/mL (100 μL/well), the concentration of rhLRP-6 Fc Chimera (Catalog # 1505-LR) that produces 50% of the optimal binding response is found to be approximately 0.4‑2 μg/mL. |
Source | E. coli-derived human USAG1 protein Phe24-Ser206, with an N-terminal Met |
Accession # | |
N-terminal Sequence | Met |
Protein/Peptide Type | Recombinant Proteins |
Gene | SOSTDC1 |
Purity | >95%, by SDS-PAGE under reducing conditions and visualized by silver stain |
Endotoxin Note | <0.10 EU per 1 μg of the protein by the LAL method. |
Dilutions |
|
|
Theoretical MW | 20.9 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
|
SDS-PAGE | 21 kDa, reducing conditions |
|
Publications |
|
Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Buffer | Lyophilized from a 0.2 μm filtered solution in HCl. |
Purity | >95%, by SDS-PAGE under reducing conditions and visualized by silver stain |
Reconstitution Instructions | Reconstitute at 250 μg/mL in 4 mM HCl. |
USAG1 (uterine sensitization‑associated gene 1), also called WISE (Wnt modulator in surface ectoderm) or Ectodin, gene name SOSTDC1, is a secreted, monomeric 26 ‑ 32 kDa glycoprotein of the sclerostin family of BMP antagonists (1 ‑ 3). Human USAG1 cDNA encodes 206 amino acids (aa), including a 23 aa signal sequence and a 183 aa mature protein with a cystine knot domain (2, 3). Mature human USAG1 shares 96 ‑ 98% aa identity with mouse, rat, canine, equine, porcine and bovine USAG1. USAG1 co‑localizes with BMP7 in the developing and adult kidney, especially in renal distal tubule cells postnatally (2, 4). It is also found in ectodermal tissues such as ameloblasts of teeth (for enamel formation), and cells of the dermal papilla (1, 2). USAG1 binds BMP‑2, ‑4, ‑6, and ‑7, sequestering BMPs and making them unavailable for BMP receptor binding (1 ‑ 5). USAG1 also binds LRPs such as LRP6, blocking LRP6 engagement of Wnt (3, 6). In dental mesenchymal cells, USAG1 is proposed to coordinate BMP, Wnt, FGF and SHH signals that regulate apoptosis during tooth development (1, 6, 7). Deletion of USAG1 results in mice with supernumerary teeth, while concurrent decreased expression of LRP5 and LRP6 restores normal tooth configurations (4 ‑ 6, 8). USAG1-/- mice show decreased susceptibility to kidney injury which is reversed by administration of a neutralizing antibody to BMP7 (4). In a mouse model of Alport syndrome, deletion of USAG1 alternates disease progression (7). These results support a proposed USAG1/WISE antagonism of BMP and Wnt signaling pathways in kidney and tooth development. USAG1 expression by uterine luminal epithelium is also associated with the timing and positioning of blastocyst implantation (9).
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.